Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 15/20 | 0.43 |
| ▸ | VNN1 | O95497 | 1/20 | 0.35 |
| ▸ | PRCP | P42785 | 1/20 | 0.34 |
| ▸ | CHIT1 | Q13231 | 1/20 | 0.34 |
| ▸ | OPRL1 | P41146 | 4/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL20210984 | 1.00 | OPRM1 (0.43) | OPRM1VNN1PRCPCHIT1OPRL1 | |
| SCHEMBL17444355 | 0.95 | OPRM1 (0.45) | OPRM1VNN1OPRL1 | |
| SCHEMBL17444354 | 0.95 | OPRM1 (0.45) | OPRM1VNN1OPRL1 | |
| SCHEMBL17443809 | 0.87 | OPRM1 (0.40) | OPRM1VNN1OPRL1HSD11B1 | |
| SCHEMBL17443808 | 0.87 | OPRM1 (0.40) | OPRM1VNN1OPRL1HSD11B1 | |
| Trifluoroacetic Acid SCHEMBL19137846 | 0.87 | OPRM1 (0.39) | OPRM1VNN1PRCPCHIT1OPRL1 | |
| Trifluoroacetic Acid SCHEMBL20211000 | 0.87 | OPRM1 (0.39) | OPRM1VNN1PRCPCHIT1OPRL1 | |
| Trifluoroacetic Acid SCHEMBL17444059 | 0.87 | OPRM1 (0.48) | OPRM1PRCPOPRL1HSD11B1 | |
| Trifluoroacetic Acid SCHEMBL20210987 | 0.87 | OPRM1 (0.48) | OPRM1PRCPOPRL1HSD11B1 | |
| Trifluoroacetic Acid SCHEMBL17444194 | 0.87 | OPRM1 (0.48) | OPRM1PRCPOPRL1HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3169666-B1 | SUBSTITUTED AZASPIRO(4.5)DECANE DERIVATIVES | GRUENENTHAL GMBH (DE) | 2018-06-06 | — | — | EP | claimed |
| US-20170210734-A1 | Substituted Azaspiro(4.5)Decane Derivatives | GRUENENTHAL GMBH (DE) | 2017-07-27 | — | — | US | claimed |
| EP-3169666-A1 | SUBSTITUTED AZASPIRO(4.5)DECANE DERIVATIVES | Grünenthal GmbH (DE) | 2017-05-24 | — | — | EP | claimed |
| WO-2016008582-A1 | SUBSTITUTED AZASPIRO(4.5)DECANE DERIVATIVES | Grünenthal GmbH (DE) | 2016-01-21 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170210734-A1 | Substituted Azaspiro(4.5)Decane Derivatives | OPRL1, OPRM1, OPRD1 | OPRM1 2/4885VNN1 4108/4885PRCP 3207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.